A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits

被引:46
作者
Miyanishi, K [1 ]
Yamamoto, T [1 ]
Irisa, T [1 ]
Yamashita, A [1 ]
Jingushi, S [1 ]
Noguchi, Y [1 ]
Iwamoto, Y [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan
关键词
osteonecrosis; corticosteroid; LDL/HDL cholesterol ratio; rabbit; lipid transport; bone; femoral head; risk factor;
D O I
10.1093/rheumatology/40.2.196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. This study was designed to determine the potential risk factors for corticosteroid-induced osteonecrosis (ON) based on lipid metabolism, using a rabbit ON model. Methods. Blood samples were obtained from 38 rabbits, which then received a single intramuscular injection of 20 mg/kg methylprednisolone acetate. Four weeks after the injection, the femora and humeri were examined histopathologically for the presence of ON, and the sizes of the bone marrow fat cells were also measured. Results. Rabbits with and without ON differed significantly in the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL/HDL cholesterol ratio), which is considered to be a serological marker of lipid transport (P = 0.026). The marrow fat cells were significantly larger in the rabbits with ON than in those without ON (P < 0.0001). Conclusion. A higher LDL/HDL cholesterol ratio was significantly associated with the development of ON, and such an elevated ratio may partly contribute to the increased size of marrow fat cells.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 39 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]  
BOSKEY AL, 1983, CLIN ORTHOP RELAT R, P289
[4]  
Bourke M, 1989, THEOLOGY, VXCII, P198
[5]  
BULLOUGH P.G., 1992, ATLAS ORTHOPAEDIC PA
[6]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[7]   PLASMA TRIGLYCERIDE LEVEL AND MORTALITY FROM CORONARY HEART-DISEASE [J].
CRIQUI, MH ;
HEISS, G ;
COHN, R ;
COWAN, LD ;
SUCHINDRAN, CM ;
BANGDIWALA, S ;
KRITCHEVSKY, S ;
JACOBS, DR ;
OGRADY, HK ;
DAVIS, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1220-1225
[8]  
Dobiásová M, 1998, PHYSIOL RES, V47, P387
[9]  
EBLING WF, 1985, DRUG METAB DISPOS, V13, P296
[10]  
EGAN RM, 1994, J RHEUMATOL, V21, P2376